Prognostic implications of thyroid disease in patients with atrial fibrillation
George Giannakoulas(Aristotle University of Thessaloniki), Αναστάσιος Κάρτας(Aristotle University of Thessaloniki), Dimitrios V. Moysidis(Aristotle University of Thessaloniki), Αndreas S. Papazoglou(Aristotle University of Thessaloniki), Apostolos Tzikas(AHEPA University Hospital), Αlexandra Bekiaridou(Aristotle University of Thessaloniki), Athanasios Samaras(Aristotle University of Thessaloniki), Antonios Ziakas(Aristotle University of Thessaloniki), Vasiliki Patsiou(Aristotle University of Thessaloniki), Martha Zergioti(Aristotle University of Thessaloniki), Dimitrios Kostakakis(Aristotle University of Thessaloniki), Maria-Eirini Kyriakideli(Aristotle University of Thessaloniki), Chrysanthi-Ioanna Lampropoulou(Aristotle University of Thessaloniki), Marina Spaho(Aristotle University of Thessaloniki), Amalia Baroutidou(Aristotle University of Thessaloniki)
Cited by 10
Related Papers
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
|EP Europace|2019|323
Prognostic significance of diabetes mellitus in patients with atrial fibrillation
|Cardiovascular Diabetology|2021|48
Contemporary European practice in transcatheter aortic valve implantation: results from the 2022 European TAVI Pathway Registry
|Frontiers in Cardiovascular Medicine|2023|28
Haemoptysis in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Insights on Pathophysiology, Diagnosis and Management
|Journal of Clinical Medicine|2022|22